7pzw
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 7pzw is ON HOLD | + | The entry 7pzw is ON HOLD until Paper Publication |
Authors: Ryan, M.D., Pallin, T.D., Lamers, M.B.A.C., Leonard, P.M. | Authors: Ryan, M.D., Pallin, T.D., Lamers, M.B.A.C., Leonard, P.M. | ||
| Line 8: | Line 8: | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
[[Category: Pallin, T.D]] | [[Category: Pallin, T.D]] | ||
| + | [[Category: Ryan, M.D]] | ||
[[Category: Lamers, M.B.A.C]] | [[Category: Lamers, M.B.A.C]] | ||
[[Category: Leonard, P.M]] | [[Category: Leonard, P.M]] | ||
| - | [[Category: Ryan, M.D]] | ||
Revision as of 15:29, 15 December 2021
Unreleased structure
The entry 7pzw is ON HOLD until Paper Publication
Authors: Ryan, M.D., Pallin, T.D., Lamers, M.B.A.C., Leonard, P.M.
Description: LpxC Inhibitors With Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Antibiotic With Activity Against Multidrug-Resistant Gram-Negative Bacteria
